Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | CELL AND GENE THERAPY CATAPULT |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | £180,000 |
| Release Date: | 4 July 2022 |
| Application Deadline: |
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
5 August 2022
Closed
Estimated Value
£180,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| 5 August 2022 |
| Procurement ID (OCID): | ocds-h6vhtk-034db7 |
| Notice Reference: | 018191-2022 |
Cell Therapy Catapult Ltd is seeking to contract with a suitably capable Bidder to provide the Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector. The supplier will need to perform laboratory experiments and data analysis. If you are interested in this opportunity please access the tender documents via the link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f
Document pack· 1 file
Premarket Engagement for the Future Purchase of a Liquid Chromatography-Mass Spectrometer
CELL AND GENE THERAPY CATAPULT · WAC-154705
Premarket Engagement for the Future Purchase of a Fluorescence Activated Cell Sorter (FACS) Instrument and Associated Post Installation Services
CELL AND GENE THERAPY CATAPULT · WAC-183546
Premarket Engagement Specification for Custom column packing service (cGMP and non-cGMP grade)
CELL AND GENE THERAPY CATAPULT · WAC-183565